The next challenge in the Small Business Innovation Research (SBIR) grants program is closing soon. The SBIR program supports innovators to develop and test new, commercially viable solutions to complex Queensland Government challenges.
Open for applications until 29th May, the next challenge in the program is for optimising medication use in the Emergency Department.
Details of the challenge
The SBIR program releases challenges and funds the development of innovative solutions through a staged procurement process.
This challenge is to optimise medication use in emergency departments by accelerating the uptake of new health and medical knowledge into effective and sustained changes to clinical practice and health service delivery in hospital emergency departments.
Selected innovators stand to share in up to $250,000 for the Feasibility stage, with a further $500,000 available in the Proof of Concept stage for solutions which have demonstrated their feasibility.
About the SBIR progam
The SBIR program is for any organisation able to deliver a solution to one of the published challenges.
The Advance Queensland Small Business Innovation Research (SBIR) program awards contracts to innovators to research, develop and test their solutions to complex challenges. The program is based on highly successful programs run in the United Kingdom and United States of America and aims to:
- address pressing challenges facing Queensland
- support innovative businesses to develop new products and services, grow and create jobs
- help the Queensland Government innovate to deliver improved frontline services.
- Successful applicants retain all intellectual property they develop within the SBIR program, and have the potential to secure a government lead customer for a tried and tested product which is ready to attract further investment.
How to apply
To apply, you must meet all requirements to promptly enter into a commercial contract with the Queensland Government and commence work should you be successful.
Applications close at 2.00pm (AEST), Tuesday 29 May 2018.